DCM
IMGN

Driehaus Capital Management’s Immunogen Inc IMGN Stock Holding History

Driehaus Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-195,980
Closed -$5.81M – 464
2023
Q4 		$5.81M Sell
195,980
-1,244,072
-86% -$24.8M 0.07% 261
2023
Q3 		$22.9M Buy
1,440,052
+263,922
+22% +$4.39M 0.3% 109
2023
Q2 		$22.2M Buy
+1,176,130
New +$13.9M 0.28% 114
2022
Q3 		– Sell
-330,909
Closed -$1.49M – 421
2022
Q2 		$1.49M Buy
330,909
+80,909
+32% +$352K 0.02% 298
2022
Q1 		$1.19M Hold
250,000
– – 0.01% 324
2021
Q4 		$1.85M Buy
+250,000
New +$1.55M 0.02% 305
2017
Q3 		– Sell
-67,739
Closed -$482K – 630
2017
Q2 		$482K Buy
+67,739
New +$310K 0.02% 415
2015
Q3 		– Sell
-173,720
Closed -$2.5M – 634
2015
Q2 		$2.5M Buy
+173,720
New +$1.91M 0.09% 298

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Driehaus Capital Management's IMGN Position: Q1 2024 in Review

Driehaus Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 195,980 shares — an estimated $5.81M sold.

Driehaus Capital Management first reported a position in IMGN in Q2 2015 and held it in 8 quarters. The position peaked at $22.9M in Q3 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Driehaus Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Driehaus Capital Management sold 195,980 Immunogen Inc shares in Q1 2024, an estimated $5.81M.
  • Driehaus Capital Management first reported a position in Immunogen Inc in Q2 2015 and held it in 8 quarters.
  • Driehaus Capital Management's Immunogen Inc position peaked at $22.9M in Q3 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Driehaus Capital Management's 13F filing for Q1 2024, filed 15 May 2024.